Header cover image

Investing Ideas
/
Swedish Pharmaceuticals & Biotech nse greoth potential

Swedish Pharmaceuticals & Biotech nse greoth potential

Results

15

0 new

nse greoth potential

15 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	SCOL Scandion Oncology	SEK 0.14	11.7%	-90.7%	SEK 33.2m	n/a	PB0.7x	E75.3%	n/a
	CAMX Camurus	SEK 630.50	-5.0%	107.4%	SEK 37.0b	SEK 742.67	PE165.6x	E75.0%	n/a
	MAGLE Magle Chemoswed Holding	SEK 39.00	-1.0%	22.6%	SEK 421.2m	SEK 50.00	PE54.7x	E72.2%	n/a
	XBRANE Xbrane Biopharma	SEK 0.16	-13.3%	-99.4%	SEK 240.1m	n/a	PS1.3x	E118.0%	n/a
	BIOVIC B Biovica International	SEK 2.65	-7.0%	-66.9%	SEK 239.0m	SEK 6.20	PS33x	E78.5%	n/a
	IMMU Mendus	SEK 8.50	5.2%	1.5%	SEK 428.0m	SEK 36.00	PS13.5x	E104.6%	n/a
	XSPRAY Xspray Pharma	SEK 48.75	4.4%	21.6%	SEK 1.6b	SEK 76.00	PB2.5x	E122.4%	n/a
	SENZA SenzaGen	SEK 7.00	-6.0%	-14.4%	SEK 206.5m	SEK 16.00	PS3.7x	E109.9%	n/a
	DVYSR Devyser Diagnostics	SEK 131.00	12.0%	96.1%	SEK 2.2b	SEK 150.13	PS11x	E109.0%	n/a
	EGTX Egetis Therapeutics	SEK 4.51	-5.7%	2.9%	SEK 1.3b	SEK 11.40	PS18.6x	E90.0%	n/a
	RLS RLS Global	SEK 0.45	-0.2%	-84.2%	SEK 35.6m	SEK 7.00	PS33.1x	E92.8%	n/a
	GENO Genovis AB (publ.)	SEK 23.20	2.2%	-47.6%	SEK 1.5b	SEK 43.00	PE88.1x	E28.8%	n/a
	PROB Probi	SEK 252.00	-3.1%	33.0%	SEK 2.9b	n/a	PE209.6x	E50.0%	0.5%
	BIOT Biotage	SEK 185.20	2.3%	77.4%	SEK 14.8b	SEK 193.33	PE59.1x	E20.4%	0.9%
	SECARE Swedencare	SEK 43.72	-2.1%	-2.9%	SEK 6.9b	SEK 63.00	PE91.3x	E56.1%	0.5%

Page 1 of 1